Found: 9
Select item for more details and to access through your institution.
What do we mean when we write 'senescence,''apoptosis,''necrosis,' or 'clearance of dying cells'? Mevorach et al. What do we mean by clearance of dying cells?
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1209, n. 1, p. 1, doi. 10.1111/j.1749-6632.2010.05774.x
- By:
- Publication type:
- Article
Role of class A human thrombospondins in the clearance of dying cells and tolerance induction Tabib et al. Thrombospondins and clearance of apoptotic cells.
- Published in:
- Annals of the New York Academy of Sciences, 2010, v. 1209, n. 1, p. 43, doi. 10.1111/j.1749-6632.2010.05773.x
- By:
- Publication type:
- Article
Apoptotic Cells Induce NF-κB and Inflammasome Negative Signaling.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0122440
- By:
- Publication type:
- Article
Thrombospondin-1-N-Terminal Domain Induces a Phagocytic State and Thrombospondin-1-C-Terminal Domain Induces a Tolerizing Phenotype in Dendritic Cells.
- Published in:
- PLoS ONE, 2009, v. 4, n. 8, p. 1, doi. 10.1371/journal.pone.0006840
- By:
- Publication type:
- Article
Complement-membrane regulatory proteins are absent from the nodes of Ranvier in the peripheral nervous system.
- Published in:
- Journal of Neuroinflammation, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12974-023-02920-9
- By:
- Publication type:
- Article
Complement-membrane regulatory proteins are absent from the nodes of Ranvier in the peripheral nervous system.
- Published in:
- Journal of Neuroinflammation, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12974-023-02920-9
- By:
- Publication type:
- Article
Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Identification and Characterization of Two Human Monocyte-Derived Dendritic Cell Subpopulations with Different Functions in Dying Cell Clearance and Different Patterns of Cell Death.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0162984
- By:
- Publication type:
- Article
Eculizumab Is Safe and Effective as a Long-term Treatment for Protein-losing Enteropathy Due to CD55 Deficiency.
- Published in:
- 2019
- By:
- Publication type:
- journal article